6533b853fe1ef96bd12ad055
RESEARCH PRODUCT
R-Rescovitine (Seliciclib) inhibits DNA damage-induced Cyclin A1 up-regulation and hinders non-homologous end joining: a rationale for therapeutic combinations with DNA damaging agents.
Mario Federicosubject
Settore MED/06 - Oncologia Medicahinders non-homologous end joiningtherapeutic combinationR_Rescovitine inhibits DNA damage-induced Cyclin A1 up-regulationyear | journal | country | edition | language |
---|---|---|---|---|
2011-03-29 |